Hyperketonemia induces upregulation of lfa-1 in monocytes, which is mediated by ros and p38 mapk activation

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 12, 2012, Pages 1642-1646

  Rains, Justin L ^a   Kanikarla Marie, Preeti ^a   Jain, Sushil K ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Adhesion molecules; Inflammation; Ketosis; Type 1 diabetes

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ACETYLCYSTEINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; REACTIVE OXYGEN METABOLITE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HYPERKETONEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MONOCYTE; OXIDATIVE STRESS; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; ACETYLCYSTEINE; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CELLS, CULTURED; HUMANS; KETOSIS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MAP KINASE SIGNALING SYSTEM; MONOCYTES; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; UP-REGULATION;

EID: 84870683453     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y2012-131     Document Type: Article

References (23)

1. Abdelmegeed, M.A., Kim, S.K., Woodcroft, K.J., and Novak, R.F. 2004. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J. Pharmacol. Exp. Ther. 310(2): 728-736. doi:10.1124/jpet.104.066522. PMID:15051799.
2. Candiloros, H., Muller, S., Zeghari, N., Donner, M., Drouin, P., and Ziegler, O. 1995. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care, 18(4): 549-551. doi:10.2337/diacare.18.4.549. PMID:7497868.
3. Cipolletta, C., Ryan, K.E., Hanna, E.V., and Trimble, E.R. 2005. Activation of Peripheral Blood CD14+ Monocytes Occurs in Diabetes. Diabetes, 54(9): 2779-2786. doi:10.2337/diabetes. 54.9.2779. PMID:16123369.
4. Devaraj, S., Glaser, N., Griffen, S., Wang-Polagruto, J., Miguelino, E., and Jialal, I. 2006. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes, 55(3): 774-779. doi:10.2337/diabetes.55.03.06.db05-1417. PMID:16505242.
5. Devaraj, S., Cheung, A.T., Jialal, I., Griffen, S.C., Nguyen, D., Glaser, N., and Aoki, T. 2007. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes, 56(11): 2790-2796. doi:10.2337/db07-0784. PMID:17686944.
6. Fogelstrand, L., Hulthe, J., Hultén, L.M., Wiklund, O., and Fagerberg, B. 2004. Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia, 47(11): 1948-1952. doi:10.1007/s00125-004-1553-x. PMID:15558232.
7. Hulsmans, M., and Holvoet, P. 2009. The vicious circle between oxidative stress and inflammation in atherosclerosis. J. Cell. Mol. Med. 14(1-2): 70-78. PMID:19968738.
8. Il'yasova, D., Spasojevic, I., Base, K., Zhang, H., Wang, F., Young, S.P., et al. 2012. Urinary F2-isoprostanes as a marker of reduced risk of type 2 diabetes. Diabetes Care, 35(1): 173-174. doi: 10.2337/dc11-1502. PMID:22100959.
9. Jain, S.K., and McVie, R. 1999. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes, 48(9): 1850-1855. doi:10.2337/diabetes.48.9.1850. PMID:10480618.
10. Jain, S.K., Kannan, K., and McVie, R. 1999. Effect of hyperketonemia on blood monocytes in type-I diabetic patients and apoptosis in cultured U937 monocytes. Antioxid. Redox Signal. 1(2): 211-220. doi:10.1089/ars.1999.1.2-211. PMID:11228748.
11. Jain, S.K., Kannan, K., Lim, G., McVie, R., and Bocchini, J.A., Jr. 2002. Hyperketonemia increases tumor necrosis factor-α secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and camp deficiency. Diabetes, 51(7): 2287-2293. doi:10.2337/diabetes.51.7.2287. PMID:12086962.
12. Jain, S.K., Rains, J.L., and Croad, J.L. 2007. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxid. Redox Signal. 9(10): 1581-1590. doi:10.1089/ars.2007.1577. PMID:17665966.
13. Khullar, M., Al-Shudiefat, A.A.-R.S., Ludke, A., Binepal, G., and Singal, P.K. 2010. Oxidative stress: a key contributor to diabetic cardiomyopathy. Can. J. Physiol. Pharmacol. 88(3): 233-240. doi: 10.1139/Y10-016. PMID:20393588.
14. Kitahara, M., Eyre, H.J., Lynch, R.E., Rallison, M.L., and Hill, H.R. 1980. Metabolic activity of diabetic monocytes. Diabetes, 29(4): 251-256. PMID:6244207.
15. Madamanchi, N.R., Hakim, Z.S., and Runge, M.S. 2005. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J. Thromb. Haemost. 3(2): 254-267. doi:10.1111/j.1538-7836.2004.01085.x. PMID:15670030.
16. Mýsliwiec, J., Kretowski, A., Kinalski, M., and Kinalska, I. 1999. CD11a Expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunol. Lett. 70(1): 69-72. doi:10.1016/S0165-2478(99)00133-9. PMID:10541054.
17. Rains, J.L., and Jain, S.K. 2011a. Hyperketonemia decreases mitochondrial membrane potential and its normalization with chromium (III) supplementation in monocytes. Mol. Cell. Biochem. 349(1-2): 77-82. doi:10.1007/s11010-010-0662-8. PMID:21153866.
18. Rains, J.L., and Jain, S.K. 2011b. Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 301(2): E298-E306.
19. Roe, T.F., Crawford, T.O., Huff, K.R., Costin, G., Kaufman, F.R., and Nelson, M.D., Jr. 1996. Brain infarction in children with diabetic ketoacidosis. J. Diabetes Complications, 10(2): 100-108. doi:10.1016/1056-8727(94)00058-1. PMID:8777328.
20. Singal, P.K., Belló-Klein, A., Farahmand, F., and Sandhawalia, V. 2001. Oxidative stress and functional deficit in diabetic cardiomyopathy. Adv. Exp. Med. Biol. 498: 213-220. doi:10.1007/978-1-4615-1321-6_27. PMID:11900371.
21. Tibbles, L.A., and Woodgett, J.R. 1999. The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55(10): 1230-1254. doi: 10.1007/s000180050369. PMID:10487205.
22. Umpierrez, G.E., and Kitabchi, A.E. 2003. Diabetic ketoacidosis: risk factors and management strategies. Treat. Endocrinol. 2(2): 95-108. doi:10.2165/00024677-200302020-00003. PMID:15871546.
23. White, N.H. 2000. Diabetic Ketoacidosis in children. Endocrinol. Metab. Clin. North Am. 29(4): 657-682. doi:10.1016/S0889-8529(05)70158-4. PMID:11149156.